全文获取类型
收费全文 | 1230篇 |
免费 | 107篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 62篇 |
妇产科学 | 15篇 |
基础医学 | 102篇 |
口腔科学 | 30篇 |
临床医学 | 171篇 |
内科学 | 361篇 |
皮肤病学 | 20篇 |
神经病学 | 50篇 |
特种医学 | 242篇 |
外科学 | 92篇 |
综合类 | 42篇 |
预防医学 | 77篇 |
眼科学 | 11篇 |
药学 | 79篇 |
中国医学 | 2篇 |
肿瘤学 | 36篇 |
出版年
2021年 | 13篇 |
2020年 | 6篇 |
2019年 | 12篇 |
2018年 | 19篇 |
2017年 | 15篇 |
2016年 | 6篇 |
2015年 | 27篇 |
2014年 | 26篇 |
2013年 | 33篇 |
2012年 | 31篇 |
2011年 | 36篇 |
2010年 | 30篇 |
2009年 | 34篇 |
2008年 | 43篇 |
2007年 | 78篇 |
2006年 | 16篇 |
2005年 | 33篇 |
2004年 | 24篇 |
2003年 | 19篇 |
2002年 | 18篇 |
2001年 | 28篇 |
2000年 | 26篇 |
1999年 | 21篇 |
1998年 | 55篇 |
1997年 | 41篇 |
1996年 | 63篇 |
1995年 | 48篇 |
1994年 | 42篇 |
1993年 | 53篇 |
1992年 | 26篇 |
1991年 | 19篇 |
1990年 | 28篇 |
1989年 | 37篇 |
1988年 | 44篇 |
1987年 | 45篇 |
1986年 | 42篇 |
1985年 | 41篇 |
1984年 | 25篇 |
1983年 | 17篇 |
1982年 | 17篇 |
1981年 | 24篇 |
1980年 | 20篇 |
1979年 | 11篇 |
1978年 | 17篇 |
1977年 | 22篇 |
1976年 | 8篇 |
1975年 | 11篇 |
1971年 | 5篇 |
1970年 | 5篇 |
1969年 | 6篇 |
排序方式: 共有1396条查询结果,搜索用时 15 毫秒
101.
102.
J Dove 《Clinical orthopaedics and related research》1986,(203):135-140
The Hartshill rectangle fixation is a modification of the Luque system of segmental spinal instrumentation. The rectangle is formed from a 3/16-in stainless steel rod and incorporates a roof that allows it to fit snugly against the lamina and provides good rotational stability. The rectangle is secured to the spine by means of doubled 0.91-mm-diameter stainless steel wires. The technique of the Hartshill system in the lumbar spine is described in detail. The system has been used in 71 patients with good relief of pain and without major complication. In the first 45 cases, a simple, flat, unwelded rectangle was used, and in the last 26 the Hartshill rectangle was employed. 相似文献
103.
Pulmonary cystic disease: comparison of Pneumocystis carinii pneumatoceles and bullous emphysema due to intravenous drug abuse 总被引:6,自引:0,他引:6
A rare pulmonary manifestation of the acquired immunodeficiency syndrome or intravenous (IV) drug abuse is upper lobe cystic disease--pneumatoceles in Pneumocystis carinii pneumonia (PCP) and bullous emphysema in IV drug abuse. Because these disorders overlap, the radiographic findings in 56 patients were compared. During a 12-month period, 16 patients less than 40 years of age were found to have bullous emphysema; the 10 who were IV drug abusers constituted group 1. In the same time period, 40 patients with PCP were encountered; the eight (20%) who had or developed pneumatoceles constituted group 2. In both groups, the conventional radiographic manifestations of upper lobe cystic disease were similar. Eight patients underwent computed tomography of the chest. In five patients with bullous disease, the distribution of the bullous lesions was peripheral, with sparing of the central portions of the lungs. In contrast, PCP pneumatoceles in three patients were dispersed throughout the lung parenchyma. 相似文献
104.
105.
106.
107.
108.
The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview 总被引:1,自引:0,他引:1
109.
体外膜肺氧合技术支持治疗期间患者血乳酸浓度及其预后 总被引:2,自引:1,他引:2
目的:探讨体外膜肺氧合支持治疗患者血乳酸浓度的变化和预后。方法:于2004-12/2006-09在中国医学科学院阜外心血管病医院因脱离体外循环困难的心脏外科术后患者、扩张性心肌病和冠状动脉粥样硬化性心脏病发生心源性休克的患者共40例进行了体外膜肺氧合支持治疗,按年龄和存活预后分为4组:成人存活组、成人死亡组、儿童存活组、儿童死亡组。分析4组的治疗效果,分别抽取各组患者体外膜肺氧合建立时、体外膜肺氧合运转6h、运转中间时点、停机前6h、停机时的血乳酸浓度。结果:①体外膜肺氧合支持治疗患者40例,成人组26例,20例脱机,16例生存,10例死亡,脱机率76.9%,生存率61.5%;儿童组14例,7例脱机,5例生存,9例死亡,脱机率50.0%,生存率35.0%。②成人或儿童存活组的乳酸浓度都与死亡组有明显差别,存活组血乳酸浓度明显低于死亡组,其中建立和运转6h、中间时点的差异有显著性意义(P<0.05),其余2个时点的差异有非常显著性意义(P<0.001)。组内与建立时比较,中间时点、停止前6h、停止时差异均有显著性意义(P<0.001),血乳酸浓度逐渐降低。结论:经体外膜肺氧合支持治疗的患者,血乳酸浓度明显下降,脱机时血乳酸仍高的患者预后不良。 相似文献
110.
Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients 总被引:10,自引:0,他引:10
JW Mosley ; CE Stevens ; RD Aach ; FB Hollinger ; LT Mimms ; LR Solomon ; LH Barbosa ; GJ Nemo 《Transfusion》1995,35(1):5-12
BACKGROUND: Testing for antibody to hepatitis B core antigen (anti-HBc) as a surrogate for hepatitis C viremia is no longer needed for blood donor screening. Currently, the important question is how much its use supplements hepatitis B surface antigen (HBsAg) donor screening in preventing transfusion-transmitted hepatitis B virus (HBV) infection. STUDY DESIGN AND METHODS: In a study conducted in the 1970s, 64 blood donors were associated with 15 cases of HBV (1.0%) in 1533 transfusion recipients. Sera from 61 donors at donation and 29 follow-up visits were available for present-day assays for HBsAg, HBV DNA, anti-HBc, and antibody to HBsAg (anti-HBs). RESULTS: HBsAg was found in four previously negative blood donors; HBV DNA was limited to three of these four. Anti-HBc was detected in six HBsAg-negative donors. Two other donors were negative in all assays at donation, but positive for anti- HBc and anti-HBs 2 to 4 months later. The remaining donors were negative for all HBV markers, which left five recipient cases unexplained. No HBV transmission was observed when anti-HBs sample-to- negative control values were > or = 10. CONCLUSION: Some 33 to 50 percent of cases of hepatitis B that could be transmitted by transfusion of blood from HBsAg-negative donors are prevented by anti- HBc screening. Anti-HBc-positive donors unequivocally positive for anti- HBs should be considered noninfectious for HBV and should be allowed to donate. Anti-HBc screening of paid plasmapheresis donors, supplemented by anti-HBs testing, would reduce the amount of HBV to be processed by virus inactivation and increase the content of anti-HBs in plasma pools. 相似文献